6 Analysts Assess Amylyx Pharma: What You Need To Know
Portfolio Pulse from Benzinga Insights
Six analysts have recently shared their insights on Amylyx Pharma (NASDAQ:AMLX), with ratings ranging from bullish to bearish. The average 12-month price target is $6.33, with a high of $8.00 and a low of $3.00. Recent actions include maintaining 'Buy' ratings and lowering 'Neutral' ratings.
June 24, 2024 | 12:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Analysts have mixed views on Amylyx Pharma, with an average 12-month price target of $6.33. Recent actions include maintaining 'Buy' ratings and lowering 'Neutral' ratings.
The mixed analyst ratings and the slight decline in the average price target suggest a neutral short-term impact on Amylyx Pharma's stock price. The maintenance of 'Buy' ratings by some analysts is balanced by the lowering of 'Neutral' ratings by others.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100